Home Categories Biochemical Engineering Taltirelin
M6146335

Taltirelin , ≥98% , 103300-74-9

Synonym(s):
(4S)-Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinecarbonyl-L-histidyl-L-prolinamide;(S)-N-((S)-1-((S)-2-Carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide;(S)-N-[(Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl]-L-histidyl-L-prolinamide

CAS NO.:103300-74-9

Empirical Formula: C17H23N7O5

Molecular Weight: 405.41

MDL number: MFCD00894697

Pack Size Price Stock Quantity
5mg RMB669.60 In Stock
10mg RMB896.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 72-75°
alpha  25D -13.6° (c = 1 in water)
Density  1.447±0.06 g/cm3(Predicted)
storage temp.  Store at +4°C
form  Solid
pka 9.32±0.40(Predicted)
color  White to off-white
Water Solubility  Soluble to 50 mM in sterile water
InChIKey PGQRTQMGGUFKCM-DLOVCJGASA-N
SMILES C(N)(=O)[C@@H]1CCCN1C(=O)[C@H](C[C@@H]1NCNC1)NC(C1=CC(=O)N(C)C(=O)N1)=O

Description and Uses

Taltirelin was marketed in Japan for the treatment of neurodegenerative diseases, in particular the improvement of ataxia due to spino-cerebellar degeneration (SCD); it is the first orally-active drug in this indication. This synthetic thyrotropin-releasing hormone (TRH) analog is prepared by condensation of (S)-1-methyl-4,5-dihydroorotic acid with L-histidyl-Lprolinamide. It was shown that the S-configuration for all 3 chiral centers is crucial for CNS activity. Taltirelin is a potent agonist of the TRH receptors that shows significant effects on the cerebral monoamine systems when administered i.p. in rats. As TRH at 10-fold higher doses, taltirelin has been found to increase the extracellular levels of dopamine and its metabolites (DOPAC and HVA) as well as precursors and/or metabolites of noradrenaline and serotonin in different areas of the rat brain. Taltirelin produced an anti-ataxic activity in the Rolling mouse Nagoya, an ataxic mutant mouse. In several clinical studies performed in patients suffering from various forms of SCD, taltirelin demonstrated a statistically significant increase in the global improvement of ataxic symptoms and other neurologic abnormalities.

Taltirelin is a thyrotropin-releasing hormone analog.

RELATED PRODUCTS